Tissue factor pathway inhibitor; Its structure, function and clinical significance

Polish Journal of Pharmacology

Volumn 48, Issue 1, 1996, Pages 67-72

  Kato, Hisao ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

blood coagulation; endothelial cells; heparin; TFPI

Indexed keywords

HEPARIN BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEINASE INHIBITOR; THROMBOPLASTIN; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID SEQUENCE; BINDING SITE; BLOOD CLOTTING; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN LIPID INTERACTION; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; BINDING SITES; CHO CELLS; CHROMATOGRAPHY, GEL; CRICETINAE; FACTOR XA; HEPARIN; HUMANS; HYPERLIPIDEMIAS; KINETICS; LIPOPROTEINS;

EID: 0029933080     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Abumiya T. et al.: An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. J. Biochem., 1995, 118, 178-182.
2. Broze G. J., Jr. et al.: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry, 1990, 29, 7539-7546.
3. Enjyoji K. et al.: cDNA cloning and expression of rat tissue factor pathway inhibitor (TFFI). J. Biochem., 1992, 111, 681-687.
4. Enjyoji K. et al.: Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: A segment, Gty212-Phe243. of the third Kunitz domain is a heparin-binding site. Biochemistry, 1995, 34, 5725-5735.
5. Kamei S. et al.: Amino acid sequence and inhibitory activity of Rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. J. Biochem., 1994, 115, 708-714.
6. Kokawa T. et al.: Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler. Thromb. Vase. Biol., 1995, 15, 504-510.
7. Lindahl A. K. et al.: The present status of tissue factor pathway inhibitor. Blood Coagulat. Fibrinol., 1992. 3, 439-449.
8. Novotny W. F.: Tissue factor pathway inhibitor. Semin. Thromb. Hemostasis, 1994, 20, 101-108.
9. Rapaport S. I., Rao L. V. M.: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler. Thromb., 1992, 12, 1111-1121.
10. Wam-Cramer B. J. et al.: cDNA sequence of rabbit tissue factor pathway inhibitor. Nucl. Acids Res., 1992, 20, 3648.
11. Wesselschmidt R. L. et al.: cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. Nucl. Acids Res., 1990, 18, 6440.
12. Wun T. C. et al.: Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J. Biol. Chem., 1988, 263, 6001-6004.